Hui-min Wang
Shanghai, 200072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Retraction Notice to: Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis.
Journal: Molecular therapy. Nucleic acids
Published: November 16, 2022
Quantitative proteomics characterization of cancer biomarkers and treatment.
Journal: Molecular therapy oncolytics
Published: June 07, 2021
The power and the promise of organoid models for cancer precision medicine with next-generation functional diagnostics and pharmaceutical exploitation.
Journal: Translational oncology
Published: May 11, 2021
Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-5p-mediated ANP32E inhibition.
Journal: Journal of translational medicine
Published: February 15, 2021
microRNA-873 inhibits self-renewal and proliferation of pancreatic cancer stem cells through pleckstrin-2-dependent PI3K/AKT pathway.
Journal: Cellular signalling
Published: February 01, 2021
Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs.
Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs.
Journal: American journal of cancer research
Published: January 21, 2021
Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma.
Journal: Molecular therapy. Nucleic acids
Published: December 13, 2020
Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma.
Journal: Molecular therapy. Nucleic acids
Published: October 26, 2020
Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4.
Journal: Cell death discovery
Published: September 17, 2020
Paving the way for small-molecule drug discovery.
Journal: American journal of translational research
Published: September 08, 2020
KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation.
Journal: Journal of cellular and molecular medicine
Published: May 06, 2020
Last Updated: 09/26/2026